Overexpression of MiR-335-5p Promotes Bone Formation and Regeneration in Mice
Authors:
Open Access
- 29 July 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 32 (12) , 2466-2475
Abstract
: MicroRNAs (miRNAs) and the Wnt signaling pathway play critical roles in regulating bone development and homeostasis. Our previous study revealed high expression of miR-335-5p in osteoblasts and hypertrophic chondrocytes in mouse embryos and the ability of miR-335-5p to promote osteogenic differentiation by downregulating Wnt antagonist Dickkopf-1 (DKK1). The purpose of this study was to investigate the effects of miR-335-5p constitutive overexpression on bone formation and regeneration in vivo. To that end, we generated a transgenic mouse line specifically overexpressing miR-335-5p in osteoblasts lineage by the osterix promoter and characterized its bone phenotype. Bone histomorphometry and μCT analysis revealed higher bone mass and increased parameters of bone formation in transgenic mice than in wild-type littermates. Increased bone mass in transgenic mice bones also correlated with enhanced expression of osteogenic differentiation markers. Upon osteogenic induction, bone marrow stromal cells (BMSCs) isolated from transgenic mice displayed higher mRNA expression of osteogenic markers than wild-type mice BMSCs cultures. Protein expression of Runx2 and Osx was also upregulated in BMSC cultures of transgenic mice upon osteogenic induction, whereas that of DKK1 was downregulated. Most important, BMSCs from transgenic mice were able to repair craniofacial bone defects as shown by μCT analysis, H&E staining, and osteocalcin (OCN) immunohistochemistry of newly formed bone in defects treated with BMSCs. Taken together, our results demonstrate constitutive overexpression of miR-335-5p driven by an osterix promoter in the osteoblast lineage induces osteogenic differentiation and bone formation in mice and support the potential application of miR-335-5p–modified BMSCs in craniofacial bone regeneration. © 2017 American Society for Bone and Mineral Research.Keywords
Funding Information
- National Institutes of Health (R01DE021464, R01DE025681)
This publication has 35 references indexed in Scilit:
- Inhibition of Wnt signaling by the osteoblast-specific transcription factor OsterixProceedings of the National Academy of Sciences, 2008
- Distinct roles for Hedgehog and canonical Wnt signaling in specification,differentiation and maintenance of osteoblast progenitorsDevelopment, 2006
- Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene ExpressionJournal of Biological Chemistry, 2005
- Wnt/β-Catenin Signaling in Mesenchymal Progenitors Controls Osteoblast and Chondrocyte Differentiation during Vertebrate SkeletogenesisDevelopmental Cell, 2005
- Canonical Wnt/β-Catenin Signaling Prevents Osteoblasts from Differentiating into ChondrocytesDevelopmental Cell, 2005
- Regulation of osteoblastogenesis and bone mass by Wnt10bProceedings of the National Academy of Sciences of the United States of America, 2005
- BMP-2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine LoopJournal of Bone and Mineral Research, 2003
- High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5New England Journal of Medicine, 2002
- Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptorJournal of Cell Biology, 2002
- LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye DevelopmentCell, 2001